Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/26/2025

Testosterone Replacement Therapy Effects in Women

Effects on Body Composition

  • Women with HIV wasting have low testosterone levels, but testosterone supplementation shows some positive effects on muscle mass strength without significant weight gain or muscle mass gain 1, 2, 3
  • A meta-analysis of testosterone therapy in HIV patients showed only a minimal difference in weight between testosterone and placebo groups, indicating minimal impact on overall weight 1, 2

Comparison with Other Therapies

  • Testosterone replacement is associated with weight loss and improvements in metabolic parameters in men with obesity and hypogonadism, which may inform expectations in women 4, 5

Safety and Clinical Considerations

  • Testosterone therapy is not currently licensed for use in HIV wasting in women in Europe, and there are concerns about adverse metabolic effects of long-term testosterone administration in women 1, 2
  • Testosterone assessment should be considered in patients with signs and symptoms of hypogonadism, including decreased energy, libido, and muscle mass 4, 6
  • Monitoring should include testosterone levels 2-3 months after treatment initiation and after any dose change 6
  • The method of testosterone replacement should be selected based on individual patient factors, with transdermal preparations often preferred for convenience 6
  • The Endocrine Society recommends careful monitoring of patients on testosterone therapy, considering the potential risks and benefits 6
  • Testosterone therapy in transgender men leads to significant increases in muscle volume, quadriceps cross-sectional area, and muscle strength, which may be relevant when considering effects in cisgender women 7

Minimal Impact of Testosterone Therapy on Total Body Weight in Women

Evidence from Randomized Trials

  • In a meta‑analysis of randomized controlled trials evaluating testosterone therapy versus placebo in women, the pooled mean difference in total body weight was 1.04 kg (95 % CI 0.01–12.10 kg) favoring testosterone, indicating only a trivial increase in weight that was not clinically significant【8】.

Strength of evidence: moderate (meta‑analysis of RCTs).